METHOTREXATE CEREBROSPINAL FLUID AND SERUM CONCENTRATIONS AFTER INTERMEDIATE DOSE METHOTREXATE INFUSIONEVANS WE; HUTSON PR; STEWART CF et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 3; PP. 301-307; BIBL. 24 REF.Article

CHLORAMPHENICOL SERUM CONCENTRATION FALLS DURING CHLORAMPHERICAL SUCCINATE DOSINGNAHATA MC; POWELL DA.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 3; PP. 308-313; BIBL. 15 REF.Article

DISTRIBUTION AND PROPERTIES OF FC RECEPTORS FOR IGG ON DIFFERENT LEUCOCYTE POPULATION IN MANCOLOMBATTI M; HEUMANN D; MORETTA L et al.1981; CLIN. EXP. IMMUNOL.; ISSN 0009-9104; GBR; DA. 1981; VOL. 46; NO 2; PP. 453-458; BIBL. 18 REF.Article

EFFECT OF METFORMIN ON INSULIN BINDING TO RECEPTORS IN CULTURED HUMAN LYMPHOCYTES AND CANCER CELLSPEZZINO V; TRISCHITTA V; PURRELLO F et al.1982; DIABETOLOGIA; ISSN 0012-186X; DEU; DA. 1982; VOL. 23; NO 2; PP. 131-135; BIBL. 19 REF.Article

RESISTANCE OF SOME PHASE II BIOTRANSFORMATION PATHWAYS TO HEPATOTOXINSGREGUS Z; WATKINS JB; THOMPSON TN et al.1982; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1982; VOL. 222; NO 2; PP. 471-479; BIBL. 2 P.Article

FIXATION PROTEIQUE DES SALICYCLES AU COURS DE LA POLYARTHRITE RHUMATOIDENETTER P; MONOT C; STALARS MC et al.1982; REVUE DU RHUMATISME ET DES MALADIES OSTEO-ARTICULAIRES; ISSN 0035-2659; FRA; DA. 1982; VOL. 49; NO 6; PP. 447-452; ABS. ENG/SPA/GER; BIBL. 26 REF.Article

BIOAVAILABILITY, PHARMACOKINETICS AND EFFECTS OF GLIPIZIDE IN TYPE 2 DIABETICSWAHLIN BOLL E; ALMER LO; MELANDER A et al.1982; CLINICAL PHARMACOKINETICS; ISSN 0312-5963; AUS; DA. 1982; VOL. 7; NO 4; PP. 363-372; BIBL. 7 REF.Article

RECTAL DRUG ADMINISTRATION: CLINICAL PHARMACOKINETIC CONSIDERATIONSDEBOER AG; MOOLENAAR F; DELEEDE LGJ et al.1982; CLINICAL PHARMACOKINETICS; ISSN 0312-5963; AUS; DA. 1982; VOL. 7; NO 4; PP. 285-311; BIBL. 6 P.Article

TIME-COURSE OF TRANSPLACENTAL PASSAGE OF DIAZEPAM: INFLUENCE OF INJECTION-DELIVERY INTERVAL ON NEONATAL DRUG CONCENTRATIONSBAKKE OM; HARAM K.1982; CLINICAL PHARMACOKINETICS; ISSN 0312-5963; AUS; DA. 1982; VOL. 7; NO 4; PP. 353-362; BIBL. 2 P.Article

ACCELERATED RECONERY OF SINGLENEPHRON FUNCTION BY THE POSTISCHEMIC INFUSION OF ATP-MGCL₂GAUDIO KM; TAYLOR MR; CHAUDRY IH et al.1982; KIDNEY INTERNATIONAL; ISSN 0085-2538; USA; DA. 1982; VOL. 22; NO 1; PP. 13-20; BIBL. 20 REF.Article

GLUCOSE AND LIPID METABOLISM DURING ACEBUTOLOL AND PROPRANOLOL THERAPY OF ANGINA IN NONDIABETIC PATIENTSBIRNBAUM J; DIBIANCO R; BECKER KL et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 3; PP. 294-300; BIBL. 66 REF.Article

EFFECTS OF MORPHINE ON HUMAN PANCREATIC SECRETION: STUDIES ON PURE PANCREATIC JUICEGULLO L; PRIORI P; COSTA PL et al.1982; ; GUT; ISSN 0017-5749; GBR; DA. 1982; VOL. 23; NO 9; PP. 739-743; BIBL. 24 REF.Article

THE EFFECTS OF D-NICOTINE AND L-ISOMER ON NICOTINIC RECEPTORSIKUSHIMA S; MURAMATSU I; SAKAKIBARA Y et al.1982; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1982; VOL. 222; NO 2; PP. 463-470; BIBL. 17 REF.Article

CLINICAL PHARMACOKINETICS OF CEREBROSPINAL FLUIDBONATI M; KANTO J; TOGNONI G et al.1982; CLINICAL PHARMACOKINETICS; ISSN 0312-5963; AUS; DA. 1982; VOL. 7; NO 4; PP. 312-335; BIBL. 7 P.Article

EFFECT OF ASPIRIN ON PLATELET AGGREGATION IN DIABETES MELLITUSKHOSLA PK; SETH V; TIWARI HK et al.1982; DIABETOLOGIA; ISSN 0012-186X; DEU; DA. 1982; VOL. 23; NO 2; PP. 104-107; BIBL. 19 REF.Article

THE TIME COURSE OF DELIVERY OF FUROSEMIDE INTO URINE: AN INDEPENDENT DETERMINANT OF OVERALL RESPONSEKOJARERN S; DAY B; BARTER DC et al.1982; KIDNEY INTERNATIONAL; ISSN 0085-2538; USA; DA. 1982; VOL. 22; NO 1; PP. 69-74; BIBL. 19 REF.Article

ACEBUTOLOL: EFFICACY AND ACCEPTABILITY IN THE TREATMENT OF ESSENTIAL HYPERTENSION OVER 22 MONTHSKUBIK MM.1983; JOURNAL OF INTERNATIONAL MEDICAL RESEARCH; ISSN 0300-0605; GBR; DA. 1983; VOL. 11; NO 3; PP. 194-196; BIBL. 2 REF.Article

MEPINDOLOL PROTECTION OF PROSTACYCLIN FORMATION. SUBSEQUENT INCREASE IN ARACHIDONIC ACID-INDUCED PROSTACYCLIN RELEASE IN ISOLATED GUINEA PIG HEARTKAHLEN T; SCHROER K.1982; EUROPEAN JOURNAL OF PHARMACOLOGY; ISSN 0014-2999; NLD; DA. 1982; VOL. 82; NO 1-2; PP. 81-84; BIBL. 10 REF.Article

THROMBOCYTOPENIA PROVOKED BY CARRAGEENAN IN RABBITS AND THE INHIBITORY EFFECT OF LYSOZYMEBIANCHI C.1982; AGENTS AND ACTIONS; ISSN 0538-4818; CHE; DA. 1982; VOL. 12; NO 5-6; PP. 657-661; BIBL. 42 REF.Article

MONACO. BETA-BLOQUANTS INTERACTIONS MEDICAMENTEUSESFERRY Y.1982; GAZ. MED. FR. (1969); ISSN 0016-5557; FRA; DA. 1982; VOL. 89; NO 28; PP. 3372; BIBL. 9 REF.Article

PHYSIOLOGICAL EVIDENCE (HYPOTHERMIA) FOR CENTRAL EFFECTS OF BETA-BLOCKER AGENTSBEN URIAH Y; YEHUDA S; CARASSO RL et al.1981; INT. J. NEUROSCI.; ISSN 0020-7454; GBR; DA. 1981; VOL. 14; NO 1-2; PP. 41-46; BIBL. 31 REF.Article

ANTIHYPERTENSIVE EFFICACY OF THE NEW LONG-ACTING BETA -BLOCKER BOPINDOLOL AS RELATED TO AGEHULTHEN UL; VAN BRUMMELEN P; AMANN FW et al.1983; JOURNAL OF CARDIOVASCULAR PHARMACOLOGY; ISSN 0160-2446; USA; DA. 1983; VOL. 5; NO 3; PP. 426-429; BIBL. 14 REF.Article

CONTRIBUTION A L'ETUDE DE LA SEBORRHEE EXPERIMENTALE CHEZ LE RAT EN VUE DE L'ETUDE D'ANTISEBORRHEIQUE = CONTRIBUTION TO THE STUDY OF EXPERIMENTAL SEBORRHEA IN THE RAT WITH A VIEW TO AN ANTISEBORRHEAL STUDYCARAYOL ISABELLE.1981; ; FRA; DA. 1981; 62 P.-PL.; 30 CM; BIBL. 30 REF.; TH. D.: PHARM./TOULOUSE 3/1981/45Thesis

LES CONTRE-INDICATIONS DANS LA THERAPEUTIQUE BETA -BLOQUANTEHUGUES FC; DELLAS JA.1981; COEUR; ISSN 0010-0226; FRA; DA. 1981; VOL. 12; NO 4; PP. 377-382; ABS. ENG; BIBL. 30 REF.Article

LES EFFETS SECONDAIRES INDESIRABLES DES BETA-BLOQUANTSHUGUES FC; PENSO D; MARCHE J et al.1980; THERAPIE; FRA; DA. 1980; VOL. 35; NO 2; PP. 155-171; ABS. ENG; BIBL. 60 REF.Article